The mission of Alkermes is to provide support through grants to non-profit organizations aimed at addressing the needs of people living with addiction, serious mental illness, or cancer, particularly focusing on historically under-resourced or underrepresented communities. Their goal is to support innovative and impactful initiatives that address both acute and long-term challenges associated with these conditions.
The Alkermes Education Grants program aims to support educational activities in the medical field, particularly focusing on serious mental illnesses like schizophrenia and bipolar disorder. It encourages activities that encompass live events, print, enduring materials, and web-based continuing medical education (CME) activities. The grant underscores the importance of understanding and implementing pharmacologic approaches to address challenges such as suboptimal therapeutic responses, gaps in medication adherence, and treatment side effects. It places a strong emphasis on patient-centered approaches to optimize treatment. Moreover, Alkermes shows interest in collaborative submissions between CME providers and professional organizations, targeting professionals treating serious mental illnesses, through various educational formats. They are currently inviting proposals specifically related to schizophrenia and bipolar disorder, highlighting topics like emerging pharmacologic approaches, their mechanisms of action, and strategies to improve patient outcomes.
Alkermes U.S. Medical Education is open to reviewing proposals for educational initiatives from organizations without accreditation. Nonetheless, priority will be given to programs that are accredited, with a particular emphasis on those offering accredited Continuing Medical Education (CME) activities.